Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares US Aerospace & Defense ETF (ITA) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance

iShares US Aerospace & Defense ETFTrade
Kymera Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares US Aerospace & Defense ETF vs Kymera Therapeutics Inc. Common Stock — how do they compare? iShares US Aerospace & Defense ETF trades at $203.99 (market cap $11.96B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: iShares US Aerospace & Defense ETF is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares US Aerospace & Defense ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares US Aerospace & Defense ETF for 24 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.

ITAKYMR
Market Cap
$11.96B$8.87B
Volume
750,577779,107
Sector
Sector/ThematicHealth
52-Week High
$253.22$127.31
52-Week Low
$198.23$55.80
Typical Hold Time
24 Days0 Days
Enterprise Value
—$8.26B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares US Aerospace & Defense ETF

ITA trades at $204.00, down 0.99% with bearish technical signals from moving averages. The ETF shows neutral oscillators but faces selling pressure with RSI at oversold levels. Recent corporate actions include a 1:3 stock split scheduled for November 2026 and a $0.25 dividend payment in September 2026. Defense sector momentum remains strong with multiple contract wins and geopolitical tensions driving demand.

The defense sector outlook appears favorable with increased government spending and geopolitical tensions, though ITA faces technical headwinds. Key risks include defense budget volatility and geopolitical resolution. Analyst sentiment remains mixed with the ETF positioned to benefit from ongoing military modernization programs and replenishment of defense inventories.

Kymera Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ITA

No sentiment data available yet.

KYMR
100% Buy0% Sell
Avg holding period · 0 Days

About iShares US Aerospace & Defense ETF

iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.

Read more on ITA →

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →